HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Blooming For Spring: P&G My Black Is Beautiful, Dollar General Root To End! Hair Products

Executive Summary

My Black is Beautiful hair care expands with Blue Ginger six-product line for scalp and hair nourishment, rolling out in Sally Beauty, says P&G. Retail chain Dollar General expands its private label offerings with hair care line Root to End!

You may also be interested in...



P&G Ventures Startup Incubator Yields Supplements For Menopause Symptoms

P&G Ventures startup's partnership with venture capital group M13 delivered its first brand, the Kindra four-product, hormone-free menopausal line. Kindra says its products provide relief from the seven symptoms of menopause in a market largely neglected.

Legacy Consumer Health Firms Invest To Compete In Startups' Realm: E-Commerce

J&J, Colgate, P&G and Church & Dwight look to e-commerce to regain market share from smaller, nimble consumer health brands and digital-based retail startups, executives from the firms say at Barclays Global Consumer Staples conference.

Discount Stores, Online Retailers Grow OTC, Supplement Sales With Value, Convenience

The share of OTC drug and supplement sales for online retailers jumped 12% and increased 17% in the value channel in 2013 – a figure that demands companies “to stand up and take notice,” IRI executive Piyush Chaudhari says. Drugstores retained the largest share of consumer health care product sales, 32%.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151115

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel